BRTX vs C · rev $401.0K vs P/E 16, rev $85.22B
BioRestorative Therapies Inc (BRTX) versus Citigroup Inc. (C) — a side-by-side from cached financials, not a winner call.
BioRestorative Therapies Inc (BRTX) is a biotechnology company listed on NASDAQ.
Citigroup Inc. (C) is a banks - diversified company listed on US.
Latest reported BRTX revenue for 2024-12-31 was $401.0K. Net income was -$9.0M. Revenue was up 175.0% from 2023-12-31 to 2024-12-31. BRTX currently screens at market cap $10.2M.
Latest reported C revenue for 2025-12-31 was $85.22B. Net income was $14.31B. Revenue was up 5.0% from 2024-12-31 to 2025-12-31. C currently screens at market cap $214.73B and trailing P/E 15.5.
BRTX currently screens at market cap $10.2M. C currently screens at market cap $214.73B and trailing P/E 15.5.
Not investment advice. Open the BRTX and C stock pages for the full models.
Not investment advice.